Skip to Main Content

Paper Details

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
PLoS One
3
2022
CZP, Crohn's disease, Fc-free, KCNK5 gene, RA, SNPs, TNF, axial spondyloarthritis, certolizumab pegol, genetic variants, patients, psoriasis, psoriatic arthritis, rheumatoid arthritis, semaphorin-4G, single nucleotide polymorphisms, spondin-1, tumor necrosis factor
Author NameAffiliation
Jessica M MaiaInstitute for Genomic Medicine, Columbia University
David B GoldsteinInstitute for Genomic Medicine, Columbia University
David B GoldsteinInstitute for Genomic Medicine, Columbia University
Thomas J UrbanEshelman School of Pharmacy, University of North Carolina
  • 1 - 4

Datasets

Release 1.2